At 8.8%+ CAGR, Polymerase Chain Reaction Market to Surpass US$ 7.4 Billion by 2026: F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laborat

Continuous research and development and technology advancements in polymerase chain reaction system allows to introduce the better and affordable instruments, reagent and consumables in the field of clinical diagnosis. For instance, in March 2018, Sekisui Diagnostics launched Silaris Influenza A&B Test: an affordable, polymerase chain reaction (PCR) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis. In October 2017, Diatech Pharmacogenetics srl launched easyPGX: a ready to use in-vitro diagnostic real-time PCR product line and Helix: a polymerase chain reaction kit for the extraction of circulating free DNA from plasma.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1546

Moreover, in September 2015, Bio-Rad Laboratories launched droplet digital PCR (ddPCR) Supermix for Residual DNA Quantification. The new supermix designed to use with Bio-Rad’s Droplet Digital PCR Systems, and allows highly precise and sensitive method for DNA measurement. In November 2014, Chai Biotechnologies Inc. introduced Open qPCR: Real-Time PCR Thermocycler. The new instrument is designed to for genetic genotyping, pathogen detection, and relative DNA quantification. Moreover, In April 2014, Bio-Rad Laboratories launched Precision Blue Real-Time PCR Dye.

The new Precision Blue dye is compatible with Bio-Rad’s universal qPCR supermixes, and can be used with all Bio-Rad’s CFx real time PCR systems. In November 2012, Life Technologies Corporation launched its Applied Biosystems QuantStudio Dx Real-Time PCR Instrument, in Europe. The new PCR instrument is designed to be used in the clinical diagnostic laboratory tests such as pathogen detection, gene expression analysis, SNP genotyping, mutation detection, micro-RNA and other non-coding RNA analysis.

The global polymerase chain reaction market is projected to witness significant growth over the forecast period, owing to its wide and increasing applications in various fields, which include diagnosis of infectious diseases, such as middle ear infections, tuberculosis, Lyme disease, in forensics, including DNA fingerprinting, paternity testing and in various other molecular research applications, such as DNA sequencing, DNA cloning, and gene expression. Polymerase chain reaction is used for diagnosis of genetic disease, allowing to detect inherited genetic change or spontaneous genetic mutation.

Key players operating in polymerase chain reaction market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company, and Danaher Corporation.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1546

Detailed Segmentation:

Global Polymerase Chain Reaction Market, By Product Type:
Real Time PCR
Digital PCR
Others
Instrument
Reagents and consumables
Global Polymerase Chain Reaction Market, By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.